Publiziert in: Marktpuls, Unternehmen, Neuemissionen
Frei

CREDIT SUISSE NEW ISSUE: 6 American Call Warrants on Novartis Mittwoch, 24. November 2021 - 08:53

Dear Investor

Please find hereafter the details for these new issues:

Ticker

Valor

ISIN

Underlying

Spot

Strike

Ratio

Maturity

Type

Issue price

Impl. Vola

PDF File

GNOVCS 

11 485 0246 

CH 114 850 246 6 

Novartis AG 

CHF 76.90 

CHF 74.00 

15:1 

16.09.2022 

Call 

CHF 0.39 

17.85% 

GNOVCS_114850246_CW_TSi.pdf

HNOVCS 

11 485 0247 

CH 114 850 247 4 

Novartis AG 

CHF 76.90 

CHF 80.00 

15:1 

16.09.2022 

Call 

CHF 0.21 

17.45% 

HNOVCS_114850247_CW_TSi.pdf

INOVCS 

11 485 0248 

CH 114 850 248 2 

Novartis AG 

CHF 76.90 

CHF 84.00 

15:1 

16.09.2022 

Call 

CHF 0.14 

17.49% 

INOVCS_114850248_CW_TSi.pdf

JNOVCS 

11 485 0249 

CH 114 850 249 0 

Novartis AG 

CHF 76.90 

CHF 74.00 

15:1 

16.06.2023 

Call 

CHF 0.42 

18.06% 

JNOVCS_114850249_CW_TSi.pdf

KNOVCS 

11 485 0250 

CH 114 850 250 8 

Novartis AG 

CHF 76.90 

CHF 80.00 

15:1 

16.06.2023 

Call 

CHF 0.26 

17.85% 

KNOVCS_114850250_CW_TSi.pdf

LNOVCS 

11 485 0251 

CH 114 850 251 6 

Novartis AG 

CHF 76.90 

CHF 84.00 

15:1 

16.06.2023 

Call 

CHF 0.19 

17.91% 

LNOVCS_114850251_CW_TSi.pdf


Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.

The warrants will be placed directly in the secondary market. Please call 044/335 76 00.

Kind regards

CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08

www.credit-suisse.com

This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.